Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.100 Biomarker disease BEFREE • Reduced ADCs correlate with prognostic markers: poor differentiation and high Ki-67 expression • ADCs also significantly correlated with VEGF protein expression in primary tumours • Lower ADC values are associated with poorer survival in ovarian cancer • Whole lesion single plane-ROI ADCs may be used as a prognostic biomarker in OC. 28289938 2017
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.500 GeneticVariation disease BEFREE Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer. 22009029 2011
Entrez Id: 9683
Gene Symbol: N4BP1
N4BP1
0.010 Biomarker disease BEFREE [Corrigendum] miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1. 28498450 2017
Entrez Id: 407020
Gene Symbol: MIR28
MIR28
0.010 Biomarker disease BEFREE [Corrigendum] miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1. 28498450 2017
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.100 Biomarker disease BEFREE ZEB2 and TGF-β1 may promote EOC progression, and FIGO stage, TGF-β1 expression, postoperative start time of chemotherapy, and treatment course may be associated with the prognosis of EOC. 30814239 2017
Entrez Id: 100302203
Gene Symbol: MIR1271
MIR1271
0.030 Biomarker disease BEFREE ZEB1 reversed partial roles of miR-1271 on viability and invasion in OC. 31695412 2019
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
0.200 Biomarker disease BEFREE ZC3H18 specifically binds and activates the BRCA1 promoter to facilitate homologous recombination in ovarian cancer. 31604914 2019
Entrez Id: 3458
Gene Symbol: IFNG
IFNG
0.100 Biomarker disease BEFREE YTLDrDSLYV peptide-specific cytotoxic T lymphocyte precursor frequency was low in peripheral blood leukocytes of normal donors and patients with ovarian cancer as determined by interferon-gamma production in ELISPOT assays. 18976739 2009
Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
0.200 GeneticVariation disease BEFREE Young Ashkenazi Jewish women or those from high-risk families who test positive for BRCA1 or BRCA2 mutant genes have a significant risk of developing breast or ovarian cancer by the age of 70 years. 9508180 1998
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
0.200 GeneticVariation disease BEFREE Young Ashkenazi Jewish women or those from high-risk families who test positive for BRCA1 or BRCA2 mutant genes have a significant risk of developing breast or ovarian cancer by the age of 70 years. 9508180 1998
Entrez Id: 10413
Gene Symbol: YAP1
YAP1
0.090 Biomarker disease BEFREE Yes-associated protein 1 (YAP1) is a key transcriptional regulator in the Hippo signaling pathway that plays a critical role in the development and progression of several types of malignancies, including ovarian cancer. 28339095 2017
Entrez Id: 100302174
Gene Symbol: MIR1307
MIR1307
0.040 Biomarker disease BEFREE Xenografts assay was used to demonstrate the inhibiting effect of miR-1307 ASO and Taxol therapy against ovarian cancer in vivo. 28086946 2017
Entrez Id: 283131
Gene Symbol: NEAT1
NEAT1
0.060 Biomarker disease BEFREE Xenograft tumor model was established to confirm the biological role of NEAT1 in PTX resistance of ovarian cancer in vivo. 29180871 2017
Entrez Id: 185
Gene Symbol: AGTR1
AGTR1
0.030 Biomarker disease BEFREE Xenograft models were used to determine the role of AGTR1 in ovarian cancer metastasis. 30845964 2019
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
0.200 GeneticVariation disease BEFREE Worry about ovarian cancer risk predicted use of preventative pBSO among high-risk women including those with BRCA1/2 mutations enrolled in an ovarian cancer-screening program. 30431292 2019
Entrez Id: 7448
Gene Symbol: VTN
VTN
0.020 Biomarker disease BEFREE Wondering about the cellular origin of Vn in ovarian carcinoma, we searched for evidence of Vn synthesis by these tumors. 10053101 1999
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
0.200 GeneticVariation disease BEFREE Women with mutations in the BRCA1 or BRCA2 cancer susceptibility genes face unique choices regarding management of their high risk for breast and ovarian cancer that impact their reproductive options. 18026853 2008
Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
0.200 GeneticVariation disease BEFREE Women with germline mutations in BRCA1 and BRCA2 genes have significantly increased lifetime risks of breast and ovarian cancer. 22477030 2012
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
0.200 GeneticVariation disease BEFREE Women with germline mutations in BRCA1 are estimated to have an 85% lifetime risk of developing breast cancer and an increased but as yet undetermined risk of ovarian cancer. 8352830 1993
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
0.200 GeneticVariation disease BEFREE Women with germline mutations in BRCA1 and BRCA2 genes have significantly increased lifetime risks of breast and ovarian cancer. 22477030 2012
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
0.200 GeneticVariation disease BEFREE Women with germline mutations in BRCA1 have a greatly elevated risk of breast and ovarian cancer. 12019214 2002
Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
0.200 GeneticVariation disease BEFREE Women with germline BRCA1 or BRCA2 mutations are at substantially increased risk for breast and ovarian cancer, although the risks may not be as high as originally reported. 12514563 2003
Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
0.200 GeneticVariation disease BEFREE Women with germline BRCA1 and BRCA2 mutations have five- to 20-fold increased risks of developing breast and ovarian cancer. 22042950 2011
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
0.200 GeneticVariation disease BEFREE Women with germline BRCA1 and BRCA2 mutations have five- to 20-fold increased risks of developing breast and ovarian cancer. 22042950 2011
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
0.200 GeneticVariation disease BEFREE Women with germline BRCA1 mutation have a significant risk of breast and/or ovarian cancer. 18362067 2008